Switzerland

In order to gain access to Aerie Pharmaceuticals’ open-angle glaucoma and ocular hypertension medications, Alcon announced  that it will acquire the company…

Helsinn Group (“Helsinn”), a Swiss Biopharmaceutical Group with an innovative R&D pipeline in cancer supportive care and oncology therapeutics, strategically investing in…